| Down-regulated miRNA | Target genes | Functions | Reference |
| hsa-mir-27 | Cytochrome P450,superfamily I polypeptide 1 | Mitochondrial function | [20] |
| hsa-mir-26a,hsa-mir-27 | BCL2-antagonist/killer 1 | Apoptosis | [20] | hsa-mir-26a | Programmed cell death 10 | | [20] |
| hsa-mir-582 | Amyloid beta (A4) precursor protein | | [20] |
| hsa-mir-19 | BCL2-associated athanogene 5 | | [20] |
| hsa-mir-1180,hsa-mir-19,hsa-mir-582,hsa-mir-26a,hsa-mir-30a,hsa-let-7e,hsa-mir-545 | calcium channel, voltage-dependent, L type, alpha 1C subunit | Membrane transporters | [20] |
| hsa-mir-433,hsa-let-7e | Cathepsin C | Protein degradation | [20] | hsa-mir-26a,hsa-mir-545 | Muscle RAS oncogene homolog | Oncogene | [20] | hsa-mir-19 | RAB5B, member RAS oncogene family | | [20] |
| hsa-mir-19 | neurotrophic tyrosine kinase, receptor, type 2 | Kinases and phosphatases | [20] |
| hsa-mir-19 | Fas-activated serine/threonine kinase | | [20] |
| hsa-mir-582,hsa-let-7e | adaptor-related protein complex 1, sigma 1 subunit | trafficking and targeting proteins | [21] |
| hsa-mir-27 | actin, alpha 2, smooth muscle, aorta | cytoskeleton/motility | [21] |
|
|